Sonoma Pharmaceuticals (SNOA)
(Delayed Data from NSDQ)
$2.96 USD
-0.11 (-3.58%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $2.98 +0.02 (0.68%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Sonoma Pharmaceuticals, Inc. [SNOA]
Reports for Purchase
Showing records 1 - 8 ( 8 total )
Company: Sonoma Pharmaceuticals, Inc.
Industry: Medical - Drugs
Results for Q2/19 continue positive trend
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: Sonoma Pharmaceuticals, Inc.
Industry: Medical - Drugs
ValuEngine Detailed Valuation Report for SNOA
Provider: ValuEngine, Inc
Company: Sonoma Pharmaceuticals, Inc.
Industry: Medical - Dental Supplies
Revenues lower in Q4/18, but 2019 holds promise
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: Sonoma Pharmaceuticals, Inc.
Industry: Medical - Dental Supplies
Company: Sonoma Pharmaceuticals, Inc.
Industry: Medical - Dental Supplies
Company: Sonoma Pharmaceuticals, Inc.
Industry: Medical - Dental Supplies
SMALL-CAP SQUAWK
Provider: JGR Capital Partners
Company: Sonoma Pharmaceuticals, Inc.
Industry: Medical - Dental Supplies
Company: Sonoma Pharmaceuticals, Inc.
Industry: Medical - Dental Supplies
Oculus Innovative Sciences Announces Name Change
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
|